DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,026 filers reported holding DANAHER CORPORATION in Q2 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $655,806 | +3.4% | 2,643 | 0.0% | 0.43% | +3.1% |
| Q2 2023 | $634,395 | -4.8% | 2,643 | 0.0% | 0.42% | -8.3% |
| Q1 2023 | $666,220 | -5.0% | 2,643 | +0.1% | 0.46% | -10.6% |
| Q4 2022 | $701,057 | -3.3% | 2,641 | -5.9% | 0.51% | -7.3% |
| Q3 2022 | $725,000 | +1.8% | 2,808 | 0.0% | 0.55% | +7.0% |
| Q2 2022 | $712,000 | -15.0% | 2,808 | -1.7% | 0.52% | -7.0% |
| Q1 2022 | $838,000 | -10.6% | 2,858 | +0.4% | 0.55% | -15.4% |
| Q4 2021 | $937,000 | +8.4% | 2,847 | +0.4% | 0.66% | -0.8% |
| Q3 2021 | $864,000 | +10.5% | 2,837 | -2.6% | 0.66% | +12.4% |
| Q2 2021 | $782,000 | +21.4% | 2,912 | +1.7% | 0.59% | +13.1% |
| Q1 2021 | $644,000 | -41.8% | 2,862 | -42.5% | 0.52% | -12.0% |
| Q4 2020 | $1,106,000 | +98.6% | 4,976 | +92.3% | 0.59% | -11.8% |
| Q3 2020 | $557,000 | +18.3% | 2,588 | -2.8% | 0.67% | +8.3% |
| Q2 2020 | $471,000 | +36.5% | 2,662 | +7.0% | 0.62% | +9.2% |
| Q1 2020 | $345,000 | -16.9% | 2,489 | -8.0% | 0.57% | +18.7% |
| Q4 2019 | $415,000 | – | 2,706 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |